Report Summary
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
In 2020, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2020 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
The global Preclinical Imaging market was xx million US$ in 2020 and is expected to xx million US$ by the end of 2028, growing at a CAGR of xx% between 2022 and 2028.
This report studies the Preclinical Imaging market size (value and volume) by players, regions, product types and end industries, history data 2017-2020 and forecast data 2020-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Preclinical Imaging in these regions, from 2018 to 2028, covering
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil etc.)
- Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
- Perkinelmer
- Bruker
- Fujifilm
- Mediso
- Milabs
- MR Solutions
- Aspect Imaging
- Li-Cor Biosciences
- Trifoil Imaging
- Miltenyi Biotec
Preclinical Imaging Market, By Product Type
- Optical Imaging Systems
- Nuclear Imaging Systems
- Micro-MRI Systems
- Micro-Ultrasound Systems
- Micro-CT Systems
- Preclinical Photoacoustic Imaging Systems
- Preclinical Magnetic Particle Imaging (MPI) Systems
Preclinical Imaging Market, By End Users
- Hospital
- Diagnostics Center
- Others
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Malaysia
- Philippines
- Thailand
- Vietnam
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Rest of Central & South America
- Middle East & Africa
- GCC Countries
- Turkey
- Egypt
- South Africa
- Rest of Middle East & Africa
The study objectives of this report are:
- To study and analyze the global Preclinical Imaging market size (value & volume) by company, key regions/countries, products and application, history data from 2017 to 2020, and forecast to 2027.
- To understand the structure of Preclinical Imaging market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Preclinical Imaging manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Preclinical Imaging with respect to individual growth trends, future prospects, and their contribution to the total market.
- To project the value and volume of Preclinical Imaging submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Preclinical Imaging are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preclinical Imaging market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
- Key Stakeholders
- Raw material suppliers
- Distributors/traders/wholesalers/suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research & development (R&D) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Available Customizations:
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Preclinical Imaging market on basis of the key contributing countries. Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
1 Preclinical Imaging Market Overview
1.1 Preclinical Imaging Product Overview
1.2 Preclinical Imaging Market Segment by Type
1.2.1 Optical Imaging Systems
1.2.2 Nuclear Imaging Systems
1.2.3 Micro-MRI Systems
1.2.4 Micro-Ultrasound Systems
1.2.5 Micro-CT Systems
1.2.6 Preclinical Photoacoustic Imaging Systems
1.2.7 Preclinical Magnetic Particle Imaging (MPI) Systems
1.3 Global Preclinical Imaging Market Size by Type
1.3.1 Global Preclinical Imaging Sales and Growth by Type
1.3.2 Global Preclinical Imaging Sales and Market Share by Type (2017-2020)
1.3.3 Global Preclinical Imaging Revenue and Market Share by Type (2017-2020)
1.3.4 Global Preclinical Imaging Price by Type (2017-2020)
2 Global Preclinical Imaging Market Competition by Company
2.1 Global Preclinical Imaging Sales and Market Share by Company (2017-2020)
2.2 Global Preclinical Imaging Revenue and Share by Company (2017-2020)
2.3 Global Preclinical Imaging Price by Company (2017-2020)
2.4 Global Top Players Preclinical Imaging Manufacturing Base Distribution, Sales Area, Product Types
2.5 Preclinical Imaging Market Competitive Situation and Trends
2.5.1 Preclinical Imaging Market Concentration Rate
2.5.2 Global Preclinical Imaging Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Preclinical Imaging Company Profiles and Sales Data
3.1 Perkinelmer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Preclinical Imaging Product Category, Application and Specification
3.1.3 Perkinelmer Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Bruker
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Preclinical Imaging Product Category, Application and Specification
3.2.3 Bruker Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Fujifilm
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Preclinical Imaging Product Category, Application and Specification
3.3.3 Fujifilm Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Mediso
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Preclinical Imaging Product Category, Application and Specification
3.4.3 Mediso Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Milabs
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Preclinical Imaging Product Category, Application and Specification
3.5.3 Milabs Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 MR Solutions
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Preclinical Imaging Product Category, Application and Specification
3.6.3 MR Solutions Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Aspect Imaging
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Preclinical Imaging Product Category, Application and Specification
3.7.3 Aspect Imaging Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Li-Cor Biosciences
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Preclinical Imaging Product Category, Application and Specification
3.8.3 Li-Cor Biosciences Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Trifoil Imaging
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Preclinical Imaging Product Category, Application and Specification
3.9.3 Trifoil Imaging Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Miltenyi Biotec
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Preclinical Imaging Product Category, Application and Specification
3.10.3 Miltenyi Biotec Preclinical Imaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Preclinical Imaging Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Preclinical Imaging Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Preclinical Imaging Sales and Revenue by Regions
4.2.1 Global Preclinical Imaging Sales and Market Share by Regions (2017-2020)
4.2.2 Global Preclinical Imaging Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Preclinical Imaging Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Preclinical Imaging Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Preclinical Imaging Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Preclinical Imaging Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Preclinical Imaging Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Preclinical Imaging Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Preclinical Imaging Application/End Users
5.1 Preclinical Imaging Segment by Application
5.1.1 Hospital
5.1.2 Diagnostics Center
5.1.3 Others
5.2 Global Preclinical Imaging Product Segment by Application
5.2.1 Global Preclinical Imaging Sales by Application
5.2.2 Global Preclinical Imaging Sales and Market Share by Application (2017-2020)
6 Global Preclinical Imaging Market Forecast
6.1 Global Preclinical Imaging Sales, Revenue Forecast (2021-2027)
6.1.1 Global Preclinical Imaging Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Preclinical Imaging Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Preclinical Imaging Forecast by Regions
6.2.1 North America Preclinical Imaging Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Preclinical Imaging Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Preclinical Imaging Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Preclinical Imaging Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Preclinical Imaging Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Preclinical Imaging Forecast by Type
6.3.1 Global Preclinical Imaging Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Optical Imaging Systems Gowth Forecast
6.3.3 Nuclear Imaging Systems Gowth Forecast
6.4 Preclinical Imaging Forecast by Application
6.4.1 Global Preclinical Imaging Sales Forecast by Application (2021-2027)
6.4.2 Global Preclinical Imaging Forecast in Hospital
6.4.3 Global Preclinical Imaging Forecast in Diagnostics Center
7 Preclinical Imaging Upstream Raw Materials
7.1 Preclinical Imaging Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Preclinical Imaging Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
